Bank Julius Baer boosted its Regeneron stake by 2,886.4% in Q4 to 41,362 shares worth $31.93 million, with other institutions adjusting holdings; analysts cite a Moderate Buy rating and an average target of $826.59.Abstract: The note reports a sharp expansion of Bank Julius Baer's Regeneron holdings in Q4, rising 2,886.4% to 41,362 shares worth $31.93 million, with other institutions adjusting positions as well. Despite varied analyst perspectives, Regeneron maintains a Moderate Buy consensus and an average target of $826.59, suggesting modest upside. The move reflects continued institutional confidence in Regeneron amid ongoing biopharmaceutical activity and company performance.

NodeGuardian

2026-05-17 23:12:43

Abstract generation in progress

Bank Julius Baer & Co. Ltd Zurich significantly increased its stake in Regeneron Pharmaceuticals, Inc. by 2,886.4% in the fourth quarter, bringing its total holdings to 41,362 shares valued at $31.93 million. Other institutional investors also adjusted their positions in the biopharmaceutical company. Analysts have issued various ratings and price targets, with the stock currently holding a "Moderate Buy" consensus and an average target price of $826.59.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
TradfiTradingChallenge
300.71K Popularity
#
PlatinumCardCreatorExclusive
92.22K Popularity
#
DailyPolymarketHotspot
1.04M Popularity
#
GateSquarePizzaDay
1.77M Popularity
#
SpaceXOfficiallyFilesforIPO
563.82K Popularity

Pinned

Sitemap

Bank Julius Baer & Co. Ltd Zurich Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN

Trending Topics

TradfiTradingChallenge

PlatinumCardCreatorExclusive

DailyPolymarketHotspot

GateSquarePizzaDay

SpaceXOfficiallyFilesforIPO

Pinned